Get started
Boiron SABoiron SABoiron SA

Boiron SA

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2026
Earnings, H1 FY2026
Sep 17, 2026
Revenue and profit fell sharply, with only North America and other countries showing growth.
2025
Earnings, H2 FY2025
Annual
Apr 21, 2026
Net income nearly tripled and revenue rose, driven by North America and Asia.
Earnings, H1 FY2025
Sep 18, 2025
H1 2025 saw revenue up 7.6% and net income up 241%, led by strong US and Asia growth.
2024
Earnings, H2 FY2024
Annual
Apr 3, 2025
Net income plunged 68.4% on lower sales and restructuring costs; €1.20 dividend proposed.
Earnings, H1 FY2024
Sep 19, 2024
Revenue and profit fell sharply in H1 2024, mainly due to lower homeopathic sales.
2023
Earnings, H2 FY2023
Annual
Feb 4, 2024
Earnings, H1 FY2023
Sep 21, 2023
2022
Earnings, H2 FY2022
Annual
May 22, 2023
Earnings, H1 FY2022
Sep 15, 2022
2021
Earnings, H2 FY2021
Annual
May 20, 2022
Earnings, H1 FY2021
Sep 9, 2021
2020
Earnings, H2 FY2020
Annual
Apr 26, 2021
2019
Earnings, H2 FY2019
Annual
May 27, 2020
2018
Earnings, H2 FY2018
Annual
May 6, 2019